In prostate cancer patients, the presence of two well-known biomarkers in exosomes recovered from urine samples, such as the PCA-3 and TMPRSS2:ERG mRNAs, indicated an alternative strategy for early screening of the disease [135]. Here, ERG is linked to prostate cancer.